← Back to Clinical Trials
Recruiting NCT07203534

NCT07203534 ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07203534
Status Recruiting
Phase
Sponsor Wake Forest University Health Sciences
Condition Hematologic Malignancy
Study Type INTERVENTIONAL
Enrollment 160 participants
Start Date 2026-01-23
Primary Completion 2028-02

Trial Parameters

Condition Hematologic Malignancy
Sponsor Wake Forest University Health Sciences
Study Type INTERVENTIONAL
Phase N/A
Enrollment 160
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2026-01-23
Completion 2028-02
Interventions
Standard of CareVirtual Reality intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this research study is to see if a virtual reality (VR) headset is useful in reducing physical discomfort and anxiety experienced by patients who are scheduled to undergo a bone marrow biopsy (BMB) and/or bone marrow aspiration (BMA).

Eligibility Criteria

Inclusion Criteria: 1. Ability to understand and willingness to sign an IRB-approved informed consent directly. 2. Must be 18 years or older at time of consent. 3. Scheduled for an outpatient bone marrow biopsy (BMB) and/or bone marrow aspiration (BMA). Note that this does not need to be the participant's first BMB/BMA. 4. Participant should be suspected of or being diagnosed with a malignant hematologic disease (i.e., Acute or chronic leukemia, lymphoma, clonal plasma cell disorder, etc.) per the investigator. 5. Ability to read and understand the English language. 6. As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study Exclusion Criteria: 1. Participant is prescribed analgesics or anxiolytics for the purpose of reducing pain or anxiety prior to the procedure. 2. Participant with known intolerance to using virtual reality devices, significant motion sickness, history of seizures, histo

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology